Silence Therapeutics (SLN) Other Non-Current Assets: 2023-2025
Historic Other Non-Current Assets for Silence Therapeutics (SLN) over the last 3 years, with Sep 2025 value amounting to $399,000.
- Silence Therapeutics' Other Non-Current Assets fell 29.57% to $399,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $399,000, marking a year-over-year decrease of 29.57%. This contributed to the annual value of $3.6 million for FY2024, which is 1.54% down from last year.
- According to the latest figures from Q3 2025, Silence Therapeutics' Other Non-Current Assets is $399,000, which was down 89.80% from $3.9 million recorded in Q2 2025.
- Silence Therapeutics' Other Non-Current Assets' 5-year high stood at $3.9 million during Q2 2025, with a 5-year trough of $19,028 in Q1 2024.
- In the last 3 years, Silence Therapeutics' Other Non-Current Assets had a median value of $2.1 million in 2024 and averaged $2.0 million.
- Data for Silence Therapeutics' Other Non-Current Assets shows a peak YoY increase of 18,893.29% (in 2025) and a maximum YoY decrease of 29.57% (in 2025) over the last 5 years.
- Silence Therapeutics' Other Non-Current Assets (MRQ) stood at $3.6 million in 2023, then dropped by 1.54% to $3.6 million in 2024, then plummeted by 88.89% to $399,000 in 2025.
- Its Other Non-Current Assets was $399,000 in Q3 2025, compared to $3.9 million in Q2 2025 and $3.6 million in Q1 2025.